Oracle Closes Massive $20 Billion Capital Raise via Common Stock and Senior Notes

Overview of the Filing

On November 4, 2026, Oracle Corporation filed a Current Report on Form 8-K under Item 8.01 (Other Events) announcing the pricing and closing of dual major capital market transactions totaling $20.0 billion in aggregate proceeds:

1. $10.0 Billion Common Stock Offering:

   • Shares Issued: 86,206,897 shares of common stock ($0.01 par value).
   • Underwriting Agreement Date: November 2, 2026 (closed November 4, 2026).
   • Underwriter Purchase Price: $114.5906 per share (via representative BofA Securities, Inc.).
   • Lock-up Period: 60-day company lock-up subject to customary exceptions.

2. $10.0 Billion Senior Notes Offering:

   • Closing Date: November 4, 2026.
   • Tranche Breakdown:
     • $2.00 billion of 7.000% Notes due 2029
     • $1.75 billion of 7.450% Notes due 2031
     • $2.25 billion of 7.850% Notes due 2033
     • $2.50 billion of 8.000% Notes due 2037
     • $1.50 billion of 8.650% Notes due 2046

Use of Proceeds & Capital Allocation

Oracle stated that net proceeds from both offerings will be allocated toward general corporate purposes, including:

• Capital expenditures (e.g., cloud infrastructure and data center expansion)
• Repayment of existing indebtedness
• Strategic investments or acquisitions
• Common stock dividend payments and share repurchases

Market & Trading Impact

• Significance: High. A $20 billion financing represents a substantial corporate action.
• Dilution: The equity issuance adds approximately 86.2 million shares to Oracle's shares outstanding, causing modest shareholder dilution balanced by substantial liquidity.
• Balance Sheet & Leverage: The debt issuance locks in $10 billion in long-term fixed-rate financing across maturities spanning 3 to 20 years.